Delivery Order SPE2DB22D2005-SPE2DB25FJQN9
Award Date 7/29/25
Potential Completion Date 8/19/25
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,440.70 for XOLAIR 150 mg/mL syringes, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,440.70 for XOLAIR 150 mg/mL syringes under a firm fixed price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 26, 2025. This delivery order represents a non-competitive, non-set-aside procurement and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- This delivery order, valued at $8,644.08, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Xolair 150 mg/1.2 mL powder vials. The contract is firm fixed price with no set-aside designation, indicating competitive award. Performance will be completed by August 18, 2025, and will take place at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of XOLAIR 150 mg/ml syringes, with a contract ceiling value of $5,762.72 and an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $7,203.40 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was awarded on July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued without a set-aside designation, indicating it was competitively awarded. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $25,932.24 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xolair 150 mg/1.2 ml powder vials. The award, issued on July 21, 2025, carries a ceiling value of $16,685.00 and is structured as a firm fixed price delivery order with an ultimate completion date of August 11, 2025. This non-set-aside award was competitively awarded and represents a discrete delivery under a...
- The Defense Logistics Agency awarded a delivery order valued at $8,644.08 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XOLAIR 300 mg/2 mL syringes with a ceiling value of $1,732.19. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of August 13, 2025. The delivery order is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This contract represents a child order under a larger indefinite delivery contract vehicle,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,800.90 to AmerisourceBergen Drug Corp for the supply of XOLAIR 75 mg/0.5 ml syringes. This competitively awarded, firm fixed-price delivery order was established on August 1, 2025, with an ultimate completion date of August 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...